- The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany
-
Fick EM, Katalinic , Waldmann A
- KMID: 2403393
- Cancer Res Treat.
- 2015 Oct;47(4):747-756.
- doi: 10.4143/crt.2014.099
PURPOSE: The aim of this cross-sectional health care study (use of bisphosphonates in primary tumors of the mammae, EBisMa) is to determine how often bisphosphonate medication is used in patients... -
- CITED
-
- Close
- SHARE
-
- Close
